{"id":"W2017235356","doi":"10.1038/ki.2014.423","title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","year":2015,"lang":"en","type":"article","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":415,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences","keywords":"Eculizumab; Medicine; Thrombotic microangiopathy; Atypical hemolytic uremic syndrome; Internal medicine; Renal function; Gastroenterology; Surrogate endpoint; Kidney disease; Clinical trial; Alternative complement pathway; Phases of clinical research; Complement system; Immunology; Disease; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001234681,0.00008821089,0.0002679558,0.0001104978,0.00001630998,0.000002320417,0.0001608016,0.00005461405,0.0004244225],"category_scores_gemma":[0.001118973,0.00007966189,0.00004009267,0.00005403786,0.0001779889,0.00004488,0.0001490756,0.0000770345,0.0000374661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006184292,"about_ca_system_score_gemma":0.00009834336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007541986,"about_ca_topic_score_gemma":0.000009045519,"domain_scores_codex":[0.9991868,0.00008698092,0.0003906857,0.0001680662,0.00006868292,0.00009880492],"domain_scores_gemma":[0.9993183,0.0002279347,0.0001229665,0.0001432214,0.0001434173,0.0000441768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02090104,0.006833471,0.2501268,0.0002502601,0.006692791,0.0001913036,0.007731902,0.00008851753,0.4891635,0.01773025,0.1974317,0.002858426],"study_design_scores_gemma":[0.1587276,0.002315729,0.7074417,0.004289369,0.0006964947,0.0006958,0.008210505,0.0003960318,0.05791143,0.01111512,0.04705579,0.001144394],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961719,0.001359615,0.00002652341,0.0006804551,0.0005840429,0.0001767322,0.0007495488,0.00001212005,0.0002390646],"genre_scores_gemma":[0.9992309,0.0000341487,0.0001487952,0.00006323697,0.00001448904,0.000008239554,0.0003857275,0.000005453409,0.0001090355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4573149,"threshold_uncertainty_score":0.4647129,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04876517728652985,"score_gpt":0.3404567817363381,"score_spread":0.2916916044498082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}